By Gina Shaw
Delayed or missed doses are common among people with epilepsy taking anti-seizure medications, which are typically taken on a long-term or lifelong basis, yet the effects of missed doses are not typically assessed during clinical trials.
A new study published in Neurology by Chinese researchers used Monte Carlo simulation, based on previously identified and published population pharmacokinetic models to assess six remedial strategies for delayed or missed doses